Sinopharm Group Co. Ltd. (HKG:1099)

Sinopharm Group Statistics

Total Valuation

Sinopharm Group has a market cap or net worth of HKD 59.98 billion. The enterprise value is 142.24 billion.

Market Cap	59.98B
Enterprise Value	142.24B

Important Dates

The last earnings date was Friday, April 24, 2026.

Earnings Date	Apr 24, 2026
Ex-Dividend Date	Jun 23, 2026

Share Statistics

Sinopharm Group has 3.12 billion shares outstanding. The number of shares has decreased by -0.13% in one year.

Current Share Class	1.34B
Shares Outstanding	3.12B
Shares Change (YoY)	-0.13%
Shares Change (QoQ)	-82.27%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	29.46%
Float	1.34B

Valuation Ratios

The trailing PE ratio is 7.41 and the forward PE ratio is 6.71. Sinopharm Group's PEG ratio is 1.67.

PE Ratio	7.41
Forward PE	6.71
PS Ratio	0.09
PB Ratio	0.39
P/TBV Ratio	0.70
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	1.67

Enterprise Valuation

EV / Earnings	17.59
EV / Sales	0.22
EV / EBITDA	5.51
EV / EBIT	6.80
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.53
Debt / EBITDA	3.30
Debt / FCF	n/a
Interest Coverage	7.49

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	8.04%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	4.58%
Revenue Per Employee	6.88M
Profits Per Employee	85,206
Employee Count	94,910
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, Sinopharm Group has paid 4.48 billion in taxes.

Income Tax	4.48B
Effective Tax Rate	26.76%

Stock Price Statistics

The stock price has increased by +8.62% in the last 52 weeks. The beta is 0.60, so Sinopharm Group's price volatility has been lower than the market average.

Beta (5Y)	0.60
52-Week Price Change	+8.62%
50-Day Moving Average	20.80
200-Day Moving Average	19.85
Relative Strength Index (RSI)	35.09
Average Volume (20 Days)	4,567,379

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sinopharm Group had revenue of HKD 653.24 billion and earned 8.09 billion in profits. Earnings per share was 2.59.

Revenue	653.24B
Gross Profit	47.30B
Operating Income	19.51B
Pretax Income	16.75B
Net Income	8.09B
EBITDA	22.11B
EBIT	19.51B
Earnings Per Share (EPS)	2.59

Balance Sheet

The company has 55.47 billion in cash and 80.66 billion in debt, with a net cash position of -25.19 billion or -8.07 per share.

Cash & Cash Equivalents	55.47B
Total Debt	80.66B
Net Cash	-25.19B
Net Cash Per Share	-8.07
Equity (Book Value)	152.50B
Book Value Per Share	30.58
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Depreciation & Amortization	2.62B
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 7.24%, with operating and profit margins of 2.99% and 1.24%.

Gross Margin	7.24%
Operating Margin	2.99%
Pretax Margin	2.56%
Profit Margin	1.24%
EBITDA Margin	3.38%
EBIT Margin	2.99%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.79, which amounts to a dividend yield of 4.05%.

Dividend Per Share	0.79
Dividend Yield	4.05%
Dividend Growth (YoY)	-22.70%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.13%
Shareholder Yield	4.12%
Earnings Yield	13.48%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1